Skip to content

Depression: all studies

Page 605 of 1,034: studies 6,041 to 6,050 of 10,336, newest first. Back to the depression overview

Research

Psychedelic assisted therapy (PAT) content analysis: Discourses in United States and Netherlands

2025 Kimberly Gough

Individuals with addiction, anxiety, depression, existential distress, and post-traumatic stress disorder (PTSD), have experienced rapid and long-lasting relief of debilitating symptoms after ingestion of psychedelics.After experiencing treatment resistance or dropout, patients experienced success with psychedelics they had not with prescribed medicine.The Netherlands (NL) and the United States...

DOI: 10.46569/t722hk61m (opens in new tab) Content analysis Content measure theory Psychotherapist Psychoanalysis +1

Improving Outcomes in Psychedelic-Assisted Therapy for Opioid Addiction through Herbal Medicine

Medical Research Archives 2025 Matthew Halma, Joseph Varón, Sirjana Dhillon et al.

Psychedelic therapies have emerged as a modality of treatment for several treatment resistant diseases, including post-traumatic stress disorder (PTSD), treatment resistant depression, substance use disorders, anxiety, and obsessive-compulsive disorders. Arguably more than with other therapies, their success is dependent on the facilitator and the context of the administration. Several programs...

DOI: 10.18103/mra.v14i3.7337 (opens in new tab) Opioid use disorder Opioid addiction Addiction medicine Context archaeology +10

Psilocibina no Manejo da Depressão e Ansiedade: Uma Revisão Integrativa de Evidências Científicas

Amazônia Science & Health 2025 Ana Paula Dalmagro, Aline Bianca Montibeler, Michele Andrade

Psilocybin is an alkaloid known for its psychedelic effects by activating serotonin receptors and there is growing interest in using psilocybin to treat mental disorders such as depression and anxiety, which are not fully understood and difficult to treat with conventional medications. This research aims to review the evidence from preclinical and clinical studies on the use of psilocybin for...

Regulation as modulation: autonomic flexibility as a physiological buffer in bipolar II disorder - a perspective on somatic regulation and mood stability.

Frontiers in Psychiatry 2025 Kyndra Purcell

Bipolar II disorder is traditionally understood as a condition of mood dysregulation, yet beneath its psychological manifestations lies a physiological rhythm often overlooked: the regulation of the autonomic nervous system. This perspective proposes that while bipolar II is not caused by a dysregulated nervous system, its course-and particularly the depth and duration of depressive episodes-is...

DOI: 10.3389/fpsyt.2025.1726708 (opens in new tab) Full text (opens in new tab) Autonomic nervous system Bipolar ii disorder Heart-rate variability Mood stabilization +3

Maternal-physiological parameters and prenatal mindfulness interventions - A scoping review.

Journal of Education and Health Promotion 2025 Prathibha Lydia Braggs, Judith Angelitta Noronha, Shripad Hebbar et al.

Pregnancy is a unique experience for every woman, but it is not always easy. A good health indicator in the country is reduced maternal mortality and morbidity. How mindfulness affects maternal mental health parameters such as stress, anxiety, and depression has been well documented. However, their impact on maternal physiological parameters has not been explored much, which is the primary goal...

DOI: 10.4103/jehp.jehp_2061_24 (opens in new tab) Full text (opens in new tab) Mindfulness Body mass index Cortisol Gestational diabetes mellitus +2

Home-based psilocybin-assisted therapy for a patient with advanced cancer: A case report

Palliative & Supportive Care 2025 Houman Farzin, Brigita Koren, Helen Ferrier et al. 1 citation

Abstract Objectives Psychospiritual distress affects many patients with cancer, contributing to diminished quality of life, decreased survival and a desire for hastened death. The current standard of care, which primarily consists of antidepressants and psychotherapy, has demonstrated only modest benefits. Psilocybin-assisted therapy (PAT) has shown evidence of rapid, durable, and significant...

The Effect of Psilocybin on Cortical Neural Dynamics, Sleep-Wake Behavior, and Persistent Pain in a Rat Model

University of Michigan Library 2025 Nicholas Kolbman

Psilocybin containing mushrooms have been utilized for ceremonial, medicinal, and spiritual purposes for millennia. Recently there has been a surge of scientific interest in the therapeutic potential and mechanistic understanding of serotonergic psychedelics, including psilocybin. Psilocybin is classified as a serotonergic psychedelic because the non-ordinary state of consciousness that it...

Alternative therapy for neurological and psychiatric disorders using psilocybin

2025 Henrique Tofoli Vieira Machado, Geovana Mendes de Seixas, L. Silva et al.

Introduction: In recent years, psilocybin has been explored as an alternative therapy for neurological and psychiatric disorders, such as depression, anxiety, post-traumatic stress disorder (PTSD), and substance dependence. Studies suggest that when administered under professional supervision, psilocybin can offer relief for patients with treatment-resistant disorders. Objective: The aim of...

Attitudes Towards Psilocybin: A General Population’s Opinions on Psilocybin and Psilocybin-Assisted Therapies

Psi Chi Journal of Psychological Research 2025 Madison M. H. Simounet, Joy Drinnon

Psilocybin-assisted therapies (PAT) have been used to treat several issues including obsessive-compulsive disorder (OCD), major depressive disorder (MDD), posttraumatic stress disorder (PTSD), smoking addiction, and anxiety (Grob et al., 2011; Johnson et al., 2014; Kisely et a., 2022; Moreno et al., 2006). If more positive benefits of psilocybin are discovered, psilocybin could become a more...

Mindfulness training combined with cold water immersion effects on mood and perception of executive functioning in middle-aged and older adults: a pilot study.

Frontiers in Public Health 2025 Ambra Gentile, Sara Vivirito, Musa Kirkar et al. 1 citation

Age-related cognitive decline typically begins during middle age and persists into old age. In parallel, mood (and, in particular, anxiety and depression) can be a significant predictor of neurodegenerative pathologies. To prevent these negative consequences, mindfulness trainings were used to improve mood and executive functioning in middle-aged and older adults. Less is known about cold water...